Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Obesity has repeatedly been linked to reorganization of the gut microbiome, yet to this point obesity therapeutics have been targeted exclusively toward the human host. Here, we show that gut microbe-targeted inhibition of the trimethylamine N-oxide (TMAO) pathway protects mice against the metabolic disturbances associated with diet-induced obesity (DIO) or leptin deficiency (). Small molecule inhibition of the gut microbial enzyme choline TMA-lyase (CutC) does not reduce food intake but is instead associated with alterations in the gut microbiome, improvement in glucose tolerance, and enhanced energy expenditure. We also show that gut microbial CutC inhibition is associated with reorganization of host circadian control of both phosphatidylcholine and energy metabolism. This study underscores the relationship between microbe and host metabolism and provides evidence that gut microbe-derived trimethylamine (TMA) is a key regulator of the host circadian clock. This work also demonstrates that gut microbe-targeted enzyme inhibitors have potential as anti-obesity therapeutics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813054 | PMC |
| http://dx.doi.org/10.7554/eLife.63998 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Microbiota and kidney disease: the road ahead.
Nat Rev Nephrol
July 2025
Department of Physiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
More than 850 million individuals worldwide, accounting for 10-15% of the adult population, are estimated to have chronic kidney disease. Each of these individuals is host to tens of trillions of microorganisms that are collectively referred to as microbiota - a dynamic ecosystem that both influences host health and is itself influenced by changes in the host. Available evidence supports the existence of functional connections between resident microorganisms and kidney health that are altered in the context of specific kidney diseases, including acute kidney injury, chronic kidney disease and renal stone disease.
View Article and Find Full Text PDFMultidimensional regulation of the microbe-TLR4 signaling Axis in colorectal cancer: From molecular mechanisms to microbe-targeted therapies.
Biochim Biophys Acta Rev Cancer
July 2025
Department of Medical Microbiology, Xiangya School of Basic Medicine, Central South University, Changsha 410013, Hunan, China. Electronic address:
Colorectal cancer (CRC), the third most common cancer globally, arises from complex interactions between genetic predisposition, environmental factors, and gut microbiota dysbiosis. This review systematically analyzes the multidimensional regulatory mechanisms of the microbe-TLR4 signaling axis in CRC, including key pathways such as TLR4/NF-κB, MAPK, TRIF/IRF3, Keap1/NRF2/CYP2J2, and ceramide/β-catenin/SOAT1. These pathways drive tumor progression through metabolic reprogramming, immune modulation, and genotoxic effects.
View Article and Find Full Text PDFDecoding the Gut Microbiome in Companion Animals: Impacts and Innovations.
Microorganisms
September 2024
TREE Lab, Department of Biomedical and Life Sciences, School of Science, Navrachana University, Vadodara 391410, India.
Article Synopsis
- The evolving perception of companion animals emphasizes their importance as family members and highlights the link between gut microbiota and overall health in these animals.
- The review discusses diseases related to gut microbiome changes, including inflammatory bowel disease and obesity, and examines factors that influence gut microbiome composition like age and diet.
- It also covers detection methods for studying gut microbiota, noting their limitations, and suggests future research directions for understanding microbial interactions related to animal health.
Machine learning for data integration in human gut microbiome.
Microb Cell Fact
November 2022
Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Recent studies have demonstrated that gut microbiota plays critical roles in various human diseases. High-throughput technology has been widely applied to characterize the microbial ecosystems, which led to an explosion of different types of molecular profiling data, such as metagenomics, metatranscriptomics and metabolomics. For analysis of such data, machine learning algorithms have shown to be useful for identifying key molecular signatures, discovering potential patient stratifications, and particularly for generating models that can accurately predict phenotypes.
View Article and Find Full Text PDFBacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms.
Front Microbiol
February 2022
Gastrointestinal and Liver Unit, Prince of Wales Hospital, University of New South Wales, Sydney, NSW, Australia.
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract with unknown etiology. The pathogenesis of IBD results from immune responses to microbes in the gastrointestinal tract. Various bacterial species that are associated with human IBD have been identified.
View Article and Find Full Text PDF